{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T22:07:52Z","timestamp":1784585272526,"version":"3.55.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T00:00:00Z","timestamp":1719619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T00:00:00Z","timestamp":1719619200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1152241"],"award-info":[{"award-number":["OPP1152241"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Health Care Manag Sci"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s10729-024-09680-9","type":"journal-article","created":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T02:02:02Z","timestamp":1719885722000},"page":"436-457","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Enhancing affordability and profit in a non-cooperative, coordinated, hypothetical pediatric vaccine market via sequential optimization"],"prefix":"10.1007","volume":"27","author":[{"given":"Bruno","family":"Alves-Maciel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1806-8823","authenticated-orcid":false,"given":"Ruben A.","family":"Proano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,29]]},"reference":[{"key":"9680_CR1","unstructured":"GAVI (2020) Value of vaccination. http:\/\/www.gavi.org\/about\/value\/. [Online; accessed 18-Oct-2017]"},{"key":"9680_CR2","unstructured":"WHO (2017) Immunization coverage. http:\/\/www.who.int\/mediacentre\/factsheets\/fs378\/en\/. [Online; accessed 18-Oct-2017]"},{"key":"9680_CR3","unstructured":"Whitney CG, Zhou F, Singleton J, Schuchat A (2014) Benefits from immunization during the vaccines for children program era-United States. 1994\u20132013. MMWR. Morbidity and mortality weekly report 63(16):352\u2013355"},{"key":"9680_CR4","unstructured":"The World Bank and Gavi (2010a) Brief 12: The vaccine market-Pooled procurement. https:\/\/www.who.int\/immunization\/programmes_systems\/financing\/analyses\/Brief_12_Pooled_Procurement.pdf. [Online; accessed 19-Mar-2021]"},{"issue":"40","key":"9680_CR5","doi-asserted-by":"publisher","first-page":"5909","DOI":"10.1016\/j.vaccine.2019.07.088","volume":"37","author":"S Pagliusi","year":"2019","unstructured":"Pagliusi S, Che Y, Dong S (2019) The art of partnerships for vaccines. Vaccine 37(40):5909\u20135919","journal-title":"Vaccine"},{"key":"9680_CR6","unstructured":"Gavi (2018) About Gavi, the Vaccine Alliance.https:\/\/www.gavi.org\/about\/. [Online; accessed 26-Jun-2018]"},{"issue":"9","key":"9680_CR7","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1080\/21645515.2016.1175695","volume":"12","author":"P Le","year":"2016","unstructured":"Le P, Nghiem VT, Swint JM (2016) Post-GAVI sustainability of the Haemophilus influenzae type b vaccine program: The potential role of economic evaluation. Human Vaccines & Immunotherapeutics 12(9):2403\u20132405","journal-title":"Human Vaccines & Immunotherapeutics"},{"key":"9680_CR8","unstructured":"The World Bank and Gavi (2010b) Brief 14: The vaccine market-Tiered vaccine pricing. https:\/\/www.who.int\/immunization\/programmes_systems\/financing\/analyses\/Brief_14_Tiered_Pricing.pdf. [Online; accessed 19-Mar-2021]"},{"key":"9680_CR9","unstructured":"The World Bank (2021) How are the income group thresholds determined?. https:\/\/datahelpdesk.worldbank.org\/knowledgebase\/articles\/378833-how-are-the-income-group-thresholds-determined. [Online; accessed 18-Mar-2021]"},{"key":"9680_CR10","unstructured":"WHO (2019) Immunization coverage. https:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/immunization-coverage. [Online; accessed 27-May-2020]"},{"key":"9680_CR11","unstructured":"WHO (2017) Vaccine market: Global vaccine supply. http:\/\/www.who.int\/immunization\/programmes_systems\/procurement\/market\/global_supply\/en\/. [Online; accessed 18-Oct-2017]"},{"key":"9680_CR12","unstructured":"Sanofi (2019) Vaccination coverage. https:\/\/www.sanofi.com\/en\/your-health\/vaccines\/vaccination-coverage.[Online; accessed 27-May-2020]"},{"key":"9680_CR13","doi-asserted-by":"crossref","unstructured":"Abbas K, Procter SR, Kv Zandvoort, Clark A, Funk S, Mengistu T, Hogan D, Dansereau E, Jit M, Flasche S et al (2020) Routine childhood immunisation during the COVID-19 pandemic in Africa: A benefit-risk analysis of health benefits versus excess risk of SARS-CoV-2 infection. Lancet Glob Health 8(10):e1264\u2013e1272","DOI":"10.1016\/S2214-109X(20)30308-9"},{"issue":"1","key":"9680_CR14","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.omega.2011.03.006","volume":"40","author":"RA Proano","year":"2012","unstructured":"Proano RA, Jacobson SH, Zhang W (2012) Making combination vaccines more accessible to low-income countries: The antigen bundle pricing problem. Omega 40(1):53\u201364","journal-title":"Omega"},{"key":"9680_CR15","doi-asserted-by":"crossref","unstructured":"Hu M, Shi M, Wu J (2013) Simultaneous vs. sequential group-buying mechanisms. Management Science 59(12):2805\u20132822","DOI":"10.1287\/mnsc.2013.1740"},{"issue":"2","key":"9680_CR16","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.ejor.2016.08.069","volume":"258","author":"YC Yang","year":"2017","unstructured":"Yang YC, Cheng HK, Ding C, Li S (2017) To join or not to join group purchasing organization: A vendor\u2019s decision. Eur J Oper Res 258(2):581\u2013589","journal-title":"Eur J Oper Res"},{"issue":"2","key":"9680_CR17","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/j.1937-5956.2010.01173.x","volume":"20","author":"RR Chen","year":"2011","unstructured":"Chen RR, Roma P (2011) Group buying of competing retailers. Prod Oper Manag 20(2):181\u2013197","journal-title":"Prod Oper Manag"},{"issue":"11","key":"9680_CR18","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1287\/mnsc.49.11.1546.20582","volume":"49","author":"KS Anand","year":"2003","unstructured":"Anand KS, Aron R (2003) Group buying on the web: A comparison of price-discovery mechanisms. Manage Sci 49(11):1546\u20131562","journal-title":"Manage Sci"},{"issue":"6","key":"9680_CR19","doi-asserted-by":"publisher","first-page":"998","DOI":"10.2105\/AJPH.2013.301780","volume":"104","author":"B Behzad","year":"2014","unstructured":"Behzad B, Jacobson SH, Jokela JA, Sewell EC (2014) The relationship between pediatric combination vaccines and market effects. Am J Public Health 104(6):998\u20131004","journal-title":"Am J Public Health"},{"issue":"1","key":"9680_CR20","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1287\/serv.2016.0129","volume":"8","author":"B Behzad","year":"2016","unstructured":"Behzad B, Jacobson SH (2016) Asymmetric Bertrand-Edgeworth-Chamberlin competition with linear demand: A pediatric vaccine pricing model. Serv Sci 8(1):71\u201384","journal-title":"Serv Sci"},{"issue":"1","key":"9680_CR21","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1287\/ijoc.2013.0556","volume":"26","author":"MJ Robbins","year":"2013","unstructured":"Robbins MJ, Jacobson SH, Shanbhag UV, Behzad B (2013) The weighted set covering game: a vaccine pricing model for pediatric immunization. INFORMS J Comput 26(1):183\u2013198","journal-title":"INFORMS J Comput"},{"key":"9680_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.omega.2021.102451","volume":"103","author":"SE Martonosi","year":"2021","unstructured":"Martonosi SE, Behzad B, Cummings K (2021) Pricing the covid-19 vaccine: A mathematical approach. Omega 103:102451","journal-title":"Omega"},{"issue":"6","key":"9680_CR23","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1287\/msom.2020.0902","volume":"23","author":"K Cummings","year":"2021","unstructured":"Cummings K, Behzad B, Martonosi S (2021) Centers for disease control and prevention as a strategic agent in the pediatric vaccine market: an analytical approach. Manufacturing & Service Operations Management 23(6):1398\u20131412","journal-title":"Manufacturing & Service Operations Management"},{"key":"9680_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.omega.2020.102197","volume":"99","author":"Y Yang","year":"2021","unstructured":"Yang Y, Bidkhori H, Rajgopal J (2021) Optimizing vaccine distribution networks in low and middle-income countries. Omega 99:102197","journal-title":"Omega"},{"key":"9680_CR25","unstructured":"Medecins\u00a0Sans Frontieres (2015) The Right Shot: bringing down barriers to affordable and adapted vaccines. Medecins Sans Frontieres"},{"issue":"1","key":"9680_CR26","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1744-8603-7-39","volume":"7","author":"S Moon","year":"2011","unstructured":"Moon S, Jambert E, Childs M, Tv Schoen-Angerer (2011) A win-win solution?: A critical analysis of tiered pricing to improve access to medicines in developing countries. Glob Health 7(1):39","journal-title":"Glob Health"},{"key":"9680_CR27","unstructured":"Pfizer (2018) Global vaccine differential pricing approach. https:\/\/www.pfizer.com\/files\/health\/vaccines\/PFE_Global_Vaccines_Tiered_Pricing_Approach_03MAR2018.pdf. [Online; accessed 01-Aug-2019]"},{"key":"9680_CR28","unstructured":"GlaxoSmithKline (2014) GSK public policy positions: Tiered pricing and vaccines. https:\/\/www.gsk.com\/media\/3370\/tiered-pricing-and-vaccines-apr14.pdf. [Online; accessed 01-Aug-2019]"},{"issue":"13","key":"9680_CR29","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1016\/j.vaccine.2010.11.090","volume":"29","author":"T B\u00e4rnighausen","year":"2011","unstructured":"B\u00e4rnighausen T, Bloom DE, Canning D, Friedman A, Levine OS, O\u2019Brien J, Privor-Dumm L, Walker D (2011) Rethinking the benefits and costs of childhood vaccination: The example of the Haemophilus influenzae type b vaccine. Vaccine 29(13):2371\u20132380","journal-title":"Vaccine"},{"key":"9680_CR30","doi-asserted-by":"crossref","unstructured":"Melliez H, Levybruhl D, Boelle PY, Dervaux B, Baron S, Yazdanpanah Y (2008) Cost and cost-effectiveness of childhood vaccination against rotavirus in France. Vaccine 26(5):706\u2013715","DOI":"10.1016\/j.vaccine.2007.11.064"},{"key":"9680_CR31","doi-asserted-by":"crossref","unstructured":"Coudeville L, Paree F, Lebrun T, Jc Sailly (1999) The value of varicella vaccination in healthy children: Cost-benefit analysis of the situation in France. Vaccine 17(2):142\u2013151","DOI":"10.1016\/S0264-410X(98)00161-3"},{"issue":"3","key":"9680_CR32","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1023\/A:1025336903645","volume":"3","author":"TG McGuire","year":"2003","unstructured":"McGuire TG (2003) Setting prices for new vaccines (in advance). Int J Health Care Finance Econ 3(3):207\u2013224","journal-title":"Int J Health Care Finance Econ"},{"issue":"8","key":"9680_CR33","doi-asserted-by":"publisher","first-page":"619","DOI":"10.4161\/hv.6.8.11563","volume":"6","author":"BY Lee","year":"2010","unstructured":"Lee BY, McGlone SM (2010) Pricing of new vaccines. Hum Vaccin 6(8):619\u2013626","journal-title":"Hum Vaccin"},{"key":"9680_CR34","doi-asserted-by":"crossref","unstructured":"Stephens DS, Ahmed R, Orenstein WA (2014) Vaccines at what price? Vaccine 9(32):1029\u20131030","DOI":"10.1016\/j.vaccine.2013.12.066"},{"key":"9680_CR35","unstructured":"The World Bank (2018) Birth rate, crude (per 1,000 people). https:\/\/data.worldbank.org\/indicator\/SP.DYN.CBRT.IN. [Online; accessed 05-Aug-2018]"},{"issue":"1","key":"9680_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1023\/A:1019011106198","volume":"2","author":"SH Jacobson","year":"1999","unstructured":"Jacobson SH, Sewell EC, Deuson R, Weniger BG (1999) An integer programming model for vaccine procurement and delivery for childhood immunization: A pilot study. Health Care Manag Sci 2(1):1\u20139","journal-title":"Health Care Manag Sci"},{"issue":"19","key":"9680_CR37","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1016\/S0264-410X(98)00170-4","volume":"16","author":"BG Weniger","year":"1998","unstructured":"Weniger BG, Chen RT, Jacobson SH, Sewell EC, Deuson R, Livengood JR, Orenstein WA (1998) Addressing the challenges to immunization practice with an economic algorithm for vaccine selection. Vaccine 16(19):1885\u20131897","journal-title":"Vaccine"},{"issue":"11","key":"9680_CR38","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1097\/00006454-200111001-00008","volume":"20","author":"EC Sewel","year":"2001","unstructured":"Sewel EC, Jacobson SH, Weniger BG (2001) Reverse engineering a formulary selection algorithm to determine the economic value of pentavalent and hexavalent combination vaccines. Pediatr Infect Dis J 20(11):S45\u2013S56","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"9680_CR39","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1287\/opre.1080.0612","volume":"56","author":"SN Hall","year":"2008","unstructured":"Hall SN, Jacobson SH, Sewell EC (2008) An analysis of pediatric vaccine formulary selection problems. Oper Res 56(6):1348\u20131365","journal-title":"Oper Res"},{"issue":"10","key":"9680_CR40","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1586\/erv.12.97","volume":"11","author":"B Behzad","year":"2012","unstructured":"Behzad B, Jacobson SH, Sewell EC (2012) Pricing strategies for combination pediatric vaccines based on the lowest overall cost formulary. Expert Rev Vaccines 11(10):1189\u20131197","journal-title":"Expert Rev Vaccines"},{"issue":"1","key":"9680_CR41","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s10729-009-9109-8","volume":"13","author":"MJ Robbins","year":"2010","unstructured":"Robbins MJ, Jacobson SH, Sewell EC (2010) Pricing strategies for combination pediatric vaccines and their impact on revenue: Pediarix\u00ae or pentacel\u00ae? Health Care Manag Sci 13(1):54\u201364","journal-title":"Health Care Manag Sci"},{"issue":"1","key":"9680_CR42","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s10729-005-5214-5","volume":"8","author":"SH Jacobson","year":"2005","unstructured":"Jacobson SH, Sewell EC, Karnani T (2005) Engineering the economic value of two pediatric combination vaccines. Health Care Manag Sci 8(1):29\u201340","journal-title":"Health Care Manag Sci"},{"issue":"2","key":"9680_CR43","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1023\/A:1014437201340","volume":"5","author":"SH Jacobson","year":"2002","unstructured":"Jacobson SH, Sewell EC (2002) Using Monte Carlo simulation to determine combination vaccine price distributions for childhood diseases. Health Care Manag Sci 5(2):135\u2013145","journal-title":"Health Care Manag Sci"},{"key":"9680_CR44","unstructured":"Mosquera G (2016) Vaccine access and affordability in a coordinated market under stochastic reservation prices. https:\/\/scholarworks.rit.edu\/theses\/8957. [Online; accessed 18-Mar-2021]"},{"issue":"2","key":"9680_CR45","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1093\/heapol\/czu003","volume":"30","author":"H Saxenian","year":"2014","unstructured":"Saxenian H, Hecht R, Kaddar M, Schmitt S, Ryckman T, Cornejo S (2014) Overcoming challenges to sustainable immunization financing: early experiences from GAVI graduating countries. Health Policy Plan 30(2):197\u2013205","journal-title":"Health Policy Plan"},{"key":"9680_CR46","unstructured":"Shaginyan V, Marievsky V, Gural A, Sergeyeva T, Maksimenok E, Demchishina I (2010) Role of vaccination in reduction of Hepatitis B incidence in Ukraine. EpiNorth Journal 11(2)"},{"key":"9680_CR47","unstructured":"Gavi (2016) Co-financing policy. https:\/\/www.gavi.org\/about\/programme-policies\/co-financing\/. [Online; accessed 25-Mar-2019]"},{"key":"9680_CR48","unstructured":"WHO (2019) Vaccination coverage. https:\/\/www.who.int\/immunization\/programmes_systems\/procurement\/v3p. [Online; accessed 27-May-2020]"}],"container-title":["Health Care Management Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10729-024-09680-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10729-024-09680-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10729-024-09680-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T07:25:50Z","timestamp":1728372350000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10729-024-09680-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,29]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["9680"],"URL":"https:\/\/doi.org\/10.1007\/s10729-024-09680-9","relation":{},"ISSN":["1386-9620","1572-9389"],"issn-type":[{"value":"1386-9620","type":"print"},{"value":"1572-9389","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,29]]},"assertion":[{"value":"8 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Ethics approval (IRB) was not needed for this study","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}},{"value":"All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by Bruno Alves-Maciel, and Ruben A. Proano. The first draft of the manuscript was written by Bruno Alves-Maciel and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Contribution statement"}},{"value":"The authors have suggested the names of potential referees based on their expertise and research affinity with this study. The authors maintain no working relationship with any of the referees and have not interacted with them in ways that can influence a fair evaluation of thisstudy.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Suggested referees"}}]}}